{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T09:58:30Z","timestamp":1760954310680},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,6]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND:<\/jats:title>\n            <jats:p>Women with germline <jats:italic toggle=\"yes\">BRCA1<\/jats:italic> or <jats:italic toggle=\"yes\">BRCA2<\/jats:italic> mutations have a lifetime risk of ovarian cancer of up to 46%. Opportunistic salpingectomy has been advocated as a risk-reducing strategy owing to increasing recognition of tubal origin, yet evidence of efficacy in this high-risk population is limited.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CASE:<\/jats:title>\n            <jats:p>This is the case of a woman with a <jats:italic toggle=\"yes\">BRCA1<\/jats:italic> mutation who underwent prophylactic mastectomy and bilateral salpingectomy with ovarian retention before the age of 40 years. She did not undergo oophorectomy and subsequently developed stage IV high-grade serous ovarian cancer 4 years after her initial surgery.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION:<\/jats:title>\n            <jats:p>More research is needed to determine the role of prophylactic salpingectomy with delayed oophorectomy, optimal timing of completion oophorectomy, and the risks and benefits compared with up-front risk-reducing salpingo-oophorectomy.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aog.0000000000003864","type":"journal-article","created":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T20:41:03Z","timestamp":1588970463000},"page":"1270-1274","source":"Crossref","is-referenced-by-count":7,"title":["Ovarian Cancer After Prophylactic Salpingectomy in a Patient With Germline BRCA1 Mutation"],"prefix":"10.1097","volume":"135","author":[{"given":"Nicole","family":"Lugo Santiago","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Cox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carrie S.","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nana E.","family":"Tchabo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibraheem","family":"Awowole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vance","family":"Broach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis S.","family":"Chi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230711","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21551","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"R2-20230711","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2014.09.009","article-title":"Society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions","volume":"136","author":"Lancaster","year":"2015","journal-title":"Gynecol Oncol"},{"key":"R4-20230711","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ygyno.2014.01.018","article-title":"Risk-reducing salpingo-oophorectomy for BRCA mutation carriers: twenty years later","volume":"132","author":"Powell","year":"2014","journal-title":"Gynecol Oncol"},{"key":"R5-20230711","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/AOG.0b013e3182783c2f","article-title":"Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers","volume":"121","author":"Kwon","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R6-20230711","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/GIM.0b013e318163487d","article-title":"Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA 1 and BRCA 2 mutation carriers","volume":"10","author":"Bradbury","year":"2008","journal-title":"Genet Med"},{"key":"R7-20230711","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ajog.2013.04.019","article-title":"The role of the fallopian tube in the origin of ovarian cancer","volume":"209","author":"Erickson","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"R8-20230711","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1158\/1940-6207.CAPR-14-0293","article-title":"Salpingectomy as a means to reduce ovarian cancer risk","volume":"8","author":"Daly","year":"2015","journal-title":"Cancer Prev Res"},{"key":"R9-20230711","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ygyno.2014.02.030","article-title":"Acceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriers","volume":"133","author":"Holman","year":"2014","journal-title":"Gynecol Oncol"},{"key":"R10-20230711","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ygyno.2018.04.564","article-title":"Bilateral salpingectomy with delayed oophorectomy for ovarian cancer risk reduction: a pilot study in women with BRCA 1\/2 mutations","volume":"150","author":"Nebgen","year":"2018","journal-title":"Gynecol Oncol"},{"key":"R11-20230711","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3892\/mco.2016.1105","article-title":"High grade serous ovarian cancer 3 years after bilateral salpingectomy: a case report","volume":"6","author":"Sato","year":"2017","journal-title":"Mol Clin Oncol"},{"key":"R12-20230711","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/cncr.31211","article-title":"Peritoneal carcinomatosis after risk-reducing surgery in BRCA1\/2 mutation carriers","volume":"124","author":"Harmsen","year":"2018","journal-title":"Cancer"},{"key":"R13-20230711","doi-asserted-by":"crossref","first-page":"425.e1","DOI":"10.1016\/j.ajog.2017.06.004","article-title":"Persistence of fimbrial tissue on the ovarian surface after salpingectomy","volume":"17","author":"Gan","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"R14-20230711","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ygyno.2019.08.034","article-title":"A comparison of ovarian cancer mortality in women with BRCA1 mutations undergoing annual ultrasound screening or preventive oophorectomy","volume":"155","author":"Gronwald","year":"2017","journal-title":"Gynecol Oncol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000003864","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T21:25:30Z","timestamp":1689110730000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000003864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000003864","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]}}}